Skip to main content
. 2022 Jun 22;12(1):27–31. doi: 10.1007/s13730-022-00711-4

Table 1.

Laboratory investigations during the first half of hospital admission

Variable Reference range Day 1 Day 3 Day 6 Day 9* Day 12
Haematology
 Haemoglobin (g/L) 135–172 102 99 101 85 78
 White cells (× 109/L) 3.9–10.2 4.7 6.4 6.9 8.3 9.7
 Differential count (× 109/L)
 Lymphocytes 1.1–4.5 0.49 0.45 0.77 1.78 3.30
 Basophils 0–0.2 0.02 0.00 0.00 0.13 0.00
 Eosinophils 0.02–0.5 0.24 0.32 0.74 0.27 0.19
 Monocytes 0.1–0.9 0.42 0.96 0.49 0.56 0.29
 Neutrophils 1.5–7.7 3.23 4.67 3.98 4.73 5.72
 Platelets (× 109/L) 150–370 141 115 144 116 151
 Prothrombin time international normalised ratio 1–1.15 1.45 1.83 1.39 1.20
 Fibrinogen (g/L) 1.46–3.33 2.71 2.45 2.12 1.11
Biochemistry
 Sodium (mmol/L) 133–146 130 129 126 136 137
 Potassium (mmol/L) 3.5–5.3 4.2 4.8 5.5 4.9 4.7
 Urea (mmol/L) 2.5–7.8 12.4 15.5 28.7 11.8 31.0
 Creatinine (μmol/L) 62–115 202 311 594 137 250
 Alanine transaminase (U/L) 10–49 43 60 105 122 94
 Alkaline phosphatase (U/L) 30–130 127 223 428 910 717
 Albumin (g/L) 35–50 32 27 22 17 23
 Total bilirubin (μmol/L) 0–20 12 34 117 98 46
 Tacrolimus (μg/L) 5–8  > 30 25.5 11.3 5.1 3.6
 C-reactive protein (mg/L) 0–6 256 276 309 235 53
 Procalcitonin (ng/mL) 0–0.5 6.13 13.25 12.59
 Ferritin (μg/L) 22–322 3164.7 8937.9 8829.9 2640.0
 Triglyceride (mmol/L) 0.3–1.8 1.61 1.74 1.82 3.82
 Interleukin-1 beta (pg/mL) 0–3.1 2.04 0.10
 Interleukin-6 (pg/mL) 0–2 434.31 8.82
 Interleukin-10 (pg/mL) 0–1 20.99 14.59
 Tumour necrosis factor alpha (pg/mL) 0–5 250.19 66.82
 Interferon gamma (pg/mL) 0–10 52.84 7.81
Virology
 Nasopharyngeal SARS-CoV-2 (cycle threshold) N/A 27 15
 EBV PCR N/A 1.3 × 107
Urine analysis
 Blood N/A Neg Trace Trace
 Leukocytes N/A Neg Neg Neg
 Protein N/A 3 +  Neg

*48 h post RTX administration and commencement of dexamethasone